デオキシリボ核酸 (JP Patent Analysis Report)
The Technical Field "デオキシリボ核酸" had 665 patent application filings in the most recent period (2022-01-01 to 2022-08-31). This is a significantly decreased of -480 filings (-41.9%) over 1,145 they had in the same period of the previous year (2021-01-01 to 2021-08-31). This report also includes technical terms related to " DNA " in the search set.
The highest number of filings in 2017 with 2,029 cases, and their lowest number in 2022 with 718 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 7,898 cases in total) is 1,316, and the median is 1,703. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
| Index | Value |
|---|---|
| Average | 1,316 patents |
| Std Dev | 689 |
| COV | 0.5 |
The number of filings has been decreasing for the last 3 years (2020 to 2023).
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 718 cases | -58.2 % |
| 2021 year | 1,717 cases | +1.66 % |
| 2020 year | 1,689 cases | -9.87 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for デオキシリボ核酸 for the period of the last 10 years (2014-01-01 to 2024-04-30). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of デオキシリボ核酸, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
- Table of Contents
- Foreign Patent Analysis Report
- Patent Filing Summary for デオキシリボ核酸
- Search Set (Search Formula/Analysis Patents)
- Related Patent Analysis Report
- Competitors Information
- Top company Information
- • Information on Important Patents
- Provision of patent information to the media
- About this Site
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
デオキシリボ核酸, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of デオキシリボ核酸 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 15,331 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
デオキシリボ核酸
Same industry / competition company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as デオキシリボ核酸 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Comparing the number of applications of each company, 国立研究開発法人農業・食品産業技術総合研究機構 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 12 cases, followed by 東洋紡株式会社 with 10 cases.
| Name | Cases |
|---|---|
| 国立研究開発法人農業・食品産業技術総合研究機構 | 12 cases |
| 東洋紡株式会社 | 10 cases |
| エフホフマン-ラロシュアーゲー | 5 cases |
| 国立研究開発法人産業技術総合研究所 | 4 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 4 cases |
| 株式会社日立製作所 | 3 cases |
| ジェネンテックインコーポレイテッド | 3 cases |
| 国立研究開発法人理化学研究所 | 2 cases |
Trends in filing of joint patent applications for the target period (2014 to 2024).
Comparing the number of applications of each company, エフホフマン-ラロシュアーゲー has the highest number of joint applications in the last for the target period (2014 to 2024) with 255 cases, followed by ザリージェンツオブザユニバーシティオブカリフォルニア with 143 cases.
| Name | Cases |
|---|---|
| エフホフマン-ラロシュアーゲー | 255 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 143 cases |
| 東洋紡株式会社 | 127 cases |
| 国立研究開発法人農業・食品産業技術総合研究機構 | 97 cases |
| ジェネンテックインコーポレイテッド | 85 cases |
| 国立研究開発法人産業技術総合研究所 | 62 cases |
| 国立研究開発法人理化学研究所 | 51 cases |
| 株式会社日立製作所 | 31 cases |
| 味の素株式会社 | 27 cases |
| 武田薬品工業株式会社 | 18 cases |
| 国立研究開発法人科学技術振興機構 | 10 cases |
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
Top company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as デオキシリボ核酸 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Among the top coapplicants, 東洋紡株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 10 cases, followed by エフホフマン-ラロシュアーゲー with 5 cases.
| Name | Cases |
|---|---|
| 東洋紡株式会社 | 10 cases |
| エフホフマン-ラロシュアーゲー | 5 cases |
| 国立研究開発法人産業技術総合研究所 | 4 cases |
| 国立研究開発法人理化学研究所 | 2 cases |
Trends in filing of joint patent applications for the target period (2014 to 2024).
Among the top coapplicants, エフホフマン-ラロシュアーゲー has the highest number of joint applications in the last for the target period (2014 to 2024) with 255 cases, followed by 東洋紡株式会社 with 127 cases.
| Name | Cases |
|---|---|
| エフホフマン-ラロシュアーゲー | 255 cases |
| 東洋紡株式会社 | 127 cases |
| 国立研究開発法人産業技術総合研究所 | 62 cases |
| 国立研究開発法人理化学研究所 | 51 cases |
| 味の素株式会社 | 27 cases |
| 武田薬品工業株式会社 | 18 cases |
| 国立研究開発法人科学技術振興機構 | 10 cases |
Top company, Change in the Number of JP Patents
Below is a ranking of the number of JP patent applications by デオキシリボ核酸’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by デオキシリボ核酸’s top 7 coapplicants over the last 20 years.
Top company Details (JP)
Trends in filing of joint patent applications with 国立研究開発法人科学技術振興機構
デオキシリボ核酸 filed 10 joint applications with 国立研究開発法人科学技術振興機構 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 3 cases in total) is 0.5, and the median is 0. The coefficient of variation (standard deviation/mean) is 1.5, and there have been very big fluctuations in the number of filings from year to year.
The highest number of filings in 2015 with 5 cases, and their lowest number in 2022 with 0 cases.
| Index | Value |
|---|---|
| Average | 0.5 patents |
| Std Dev | 0.8 |
| COV | 1.5 |
| Year | Cases | YOY |
|---|---|---|
| 2020 year | 2 cases | +100 % |
| 2019 year | 1 cases | - |
| 2018 year | 0 cases | - |
Trends in filing of joint patent applications with 国立研究開発法人産業技術総合研究所
デオキシリボ核酸 filed 62 joint applications with 国立研究開発法人産業技術総合研究所 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 23 cases in total) is 3.8, and the median is 4.5. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 10 cases, and their lowest number in 2019 with 3 cases.
| Index | Value |
|---|---|
| Average | 3.8 patents |
| Std Dev | 2.0 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 4 cases | -20.00 % |
| 2021 year | 5 cases | 0 |
| 2020 year | 5 cases | +66.7 % |
Trends in filing of joint patent applications with 武田薬品工業株式会社
デオキシリボ核酸 filed 18 joint applications with 武田薬品工業株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 12 cases in total) is 2.0, and the median is 1.5. The coefficient of variation (standard deviation/mean) is 1.0, and there have been very big fluctuations in the number of filings from year to year.
The highest number of filings in 2018 with 6 cases, and their lowest number in 2022 with 0 cases.
| Index | Value |
|---|---|
| Average | 2.0 patents |
| Std Dev | 2.1 |
| COV | 1.0 |
| Year | Cases | YOY |
|---|---|---|
| 2021 year | 3 cases | +50.0 % |
| 2020 year | 2 cases | +100 % |
| 2019 year | 1 cases | -83.3 % |
Trends in filing of joint patent applications with エフホフマン-ラロシュアーゲー
デオキシリボ核酸 filed 255 joint applications with エフホフマン-ラロシュアーゲー for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 150 cases in total) is 25.0, and the median is 27.0. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2019 with 46 cases, and their lowest number in 2022 with 5 cases.
| Index | Value |
|---|---|
| Average | 25.0 patents |
| Std Dev | 17.7 |
| COV | 0.7 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 5 cases | -80.0 % |
| 2021 year | 25 cases | -44.4 % |
| 2020 year | 45 cases | -2.17 % |
Trends in filing of joint patent applications with 国立研究開発法人理化学研究所
デオキシリボ核酸 filed 51 joint applications with 国立研究開発法人理化学研究所 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 24 cases in total) is 4.0, and the median is 3.0. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2017 with 10 cases, and their lowest number in 2022 with 2 cases.
| Index | Value |
|---|---|
| Average | 4.0 patents |
| Std Dev | 3.3 |
| COV | 0.8 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 2 cases | -66.7 % |
| 2021 year | 6 cases | +50.0 % |
| 2020 year | 4 cases | -60.0 % |
Information on important patents (JP)
The following shows JP patents held by デオキシリボ核酸 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and デオキシリボ核酸’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which デオキシリボ核酸 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
Glossary
- Cited
- Indicates that the patent/patent application has been cited (by Examiners) in notices of reasons for rejection in the examination process of other (Japanese, U.S., or European) patent applications. The higher the number of citations, the more important the patent/patent application is considered to be.
- Request for invalidation trial
- Indicates that a third party has requested a procedure to invalidate the patent. It is likely to affect the business of third parties and is considered to be of high importance.
- Opposition
- Indicates that a third party has filed a petition with the Patent Office to hear the validity of the patent again. Like the trial for invalidation, it is considered to be of high importance.
- Information provision
- Indicates that a third party has provided the Patent Office with useful information for examination for the patent filed. It is usually considered to be of high importance because it is done to prevent the patent from being granted.
- Browsing request
- Indicates that a third party has requested the Patent Office to view the patent bag (a set of documents exchanged between the Patent Office and the applicant). The bag is often checked prior to trial for invalidation, opposition, and provision of information, and is considered to be a highly important patent.
Invalidationed Trial cases
List of latest Invalidationed Trial patents
In the last 3 years (2021-05-01 ~ 2024-04-30), there were 3 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.0 times. The most recently Invalidation Trial patent is 特許7016341 "ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法" (Invalidation Trial day 2023-03-27) , next is 特許6896700 "ワクチン組成物" (Invalidation Trial day 2023-01-27) .
| - | No. | Title | Invalidation Trial days |
|---|---|---|---|
| 1 | 特許7016341 | ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法 | 2023-03-27 |
| 2 | 特許6896700 | ワクチン組成物 | 2023-01-27 |
| 3 | 特許6692856 | ＲＮＡ依存性標的ＤＮＡ修飾およびＲＮＡ依存性転写調節のための方法および組成物 | 2022-02-25 |
Top Patents/Patent Applications with the Highest Number of Invalidationed Trial
Of the patent applications filed in the last 10 years (2014-05-01 to 2024-04-30), 2 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.0. The most invalidation trial patent is 特許6896700 "ワクチン組成物" (1 times) , and the next most invalidation trial patent is 特許7016341 "ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法" (1 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6896700 | ワクチン組成物 | 1 times |
| 2 | 特許7016341 | ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法 | 1 times |
Oppositioned cases
List of latest Oppositioned patents
In the last 3 years (2021-05-01 ~ 2024-04-30), there were 12 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7301332 "ＤＮＡが編集された真核細胞を製造する方法、および当該方法に用いられるキット" (Opposition day 2024-01-04) , next is 特許7289655 "ＰＡＭＰＳ及びＤＡＭＰＳの除去への血液適合性多孔性ポリマービーズ吸着剤の使用" (Opposition day 2023-12-12) .
| - | No. | Title | Opposition days |
|---|---|---|---|
| 1 | 特許7301332 | ＤＮＡが編集された真核細胞を製造する方法、および当該方法に用いられるキット | 2024-01-04 |
| 2 | 特許7289655 | ＰＡＭＰＳ及びＤＡＭＰＳの除去への血液適合性多孔性ポリマービーズ吸着剤の使用 | 2023-12-12 |
| 3 | 特許7244922 | 化学修飾された一本鎖ＲＮＡ編集オリゴヌクレオチド | 2023-09-20 |
| 4 | 特許7188087 | 一本鎖オリゴヌクレオチド | 2023-06-12 |
| 5 | 特許7180935 | 液状飲料組成物 | 2023-05-25 |
| 6 | 特許7089003 | ＲＮＡの免疫原性を低減するための方法 | 2022-12-19 |
| 7 | 特許7078812 | ＲＮＡの免疫原性を低減するための方法 | 2022-12-01 |
| 8 | 特許6988481 | 一本鎖オリゴヌクレオチド | 2022-07-04 |
| 9 | 特許6975516 | 外用組成物、化粧料、経皮吸収促進用組成物、外用組成物における有効成分の経皮吸収性を高める方法、経皮投与型医薬及び点眼用組成物 | 2022-04-14 |
| 10 | 特許6945902 | 翻訳促進剤、翻訳鋳型ｍＲＮＡ、転写鋳型ＤＮＡ、翻訳鋳型ｍＲＮＡの生産方法、および、タンパク質の生産方法 | 2022-04-05 |
Protested cases
List of latest Protested patents
In the last 3 years (2021-05-01 ~ 2024-04-30), there were 30 patents Protest from third parties. The average number of Protest is 1.2 times. The most recently Protest patent is 特表2022-518510 "薬物耐性ＭＹＣＯＰＬＡＳＭＡ ＧＥＮＩＴＡＬＩＵＭの検出" (Protest day 2024-03-13) , next is 特開2023-055917 "ＰＡＭＰＳ及びＤＡＭＰＳの除去への血液適合性多孔性ポリマービーズ吸着剤の使用" (Protest day 2024-01-17) .
| - | No. | Title | Protest days |
|---|---|---|---|
| 1 | 特表2022-518510 | 薬物耐性ＭＹＣＯＰＬＡＳＭＡ ＧＥＮＩＴＡＬＩＵＭの検出 | 2024-03-13 |
| 2 | 特開2023-055917 | ＰＡＭＰＳ及びＤＡＭＰＳの除去への血液適合性多孔性ポリマービーズ吸着剤の使用 | 2024-01-17 |
| 3 | 特許7428991 | 糖の吸収抑制用剤 | 2023-11-10 |
| 4 | 特開2021-019558 | 改良されたウイルス検出方法 | 2023-11-06 |
| 5 | 特開2021-019559 | 改良されたウイルス検出方法 | 2023-11-06 |
| 6 | 特開2022-138114 | トルコギキョウ植物を判別する方法、作出する方法、及びトルコギキョウ植物 | 2023-10-20 |
| 7 | 特許7433217 | ＲＮＡウイルスの処理方法 | 2023-08-08 |
| 8 | 特開2021-169432 | 手指消毒剤 | 2023-08-04 |
| 9 | 特許7392309 | 改良されたウイルス検出方法 | 2023-07-25 |
| 10 | 特表2021-503278 | ＣａｓＺ組成物及び使用方法 | 2023-07-06 |
| 11 | 特表2022-536157 | 改変された酸化プロトコルを使用してオリゴヌクレオチドを調製するための方法 | 2023-04-27 |
| 12 | 特表2022-527809 | 抗体コード配列をセーフハーバー遺伝子座に挿入するための方法および組成物 | 2023-03-24 |
| 13 | 特開2020-115777 | 改良された核酸検出方法 | 2023-03-13 |
| 14 | 特許7439108 | ヒト心筋トロポニンＩに対する組換え抗体 | 2023-02-27 |
| 15 | 特開2021-072833 | 核酸増幅 | 2023-01-17 |
| 16 | 特許7244922 | 化学修飾された一本鎖ＲＮＡ編集オリゴヌクレオチド | 2023-01-16 |
| 17 | 特表2021-524495 | 酸化的ストレスおよびミトコンドリアストレスから，細胞を保護する組成物 | 2022-12-16 |
| 18 | 特許6975516 | 外用組成物、化粧料、経皮吸収促進用組成物、外用組成物における有効成分の経皮吸収性を高める方法、経皮投与型医薬及び点眼用組成物 | 2022-12-14 |
| 19 | 特表2020-515255 | アルデヒドデヒドロゲナーゼバリアントおよび使用の方法 | 2022-11-01 |
| 20 | 特表2022-522823 | 天然ｍｉＲＮＡのゲノム編集による標的遺伝子発現の抑制 | 2022-10-03 |
Top Patents/Patent Applications with the Highest Number of Protested
Of the patent applications filed in the last 10 years (2014-05-01 to 2024-04-30), 58 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.2. The most protest patent is 特許6975516 "外用組成物、化粧料、経皮吸収促進用組成物、外用組成物における有効成分の経皮吸収性を高める方法、経皮投与型医薬及び点眼用組成物" (3 times) , and the next most protest patent is 特許6994730 "ゲノム編集タンパク質の直接導入による糸状菌ゲノム編集方法" (3 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6975516 | 外用組成物、化粧料、経皮吸収促進用組成物、外用組成物における有効成分の経皮吸収性を高める方法、経皮投与型医薬及び点眼用組成物 | 3 times |
| 2 | 特許6994730 | ゲノム編集タンパク質の直接導入による糸状菌ゲノム編集方法 | 3 times |
| 3 | 特表2021-524495 | 酸化的ストレスおよびミトコンドリアストレスから，細胞を保護する組成物 | 3 times |
| 4 | 特許6872307 | ホウレンソウにおけるペロノスポラ耐性のための組成物及び方法 | 2 times |
| 5 | 特許6640267 | エンドトキシン測定剤 | 2 times |
Inspectioned cases
List of latest Inspectioned patents
In the last 3 years (2021-05-01 ~ 2024-04-30), there were 243 patents Inspection from third parties. The average number of Inspection is 1.2 times. The most recently Inspection patent is 特開2022-031478 "卵巣癌の治療方法" (Inspection day 2024-04-17) , next is 特表2021-525362 "多発性骨髄腫を治療すること及び４−（４−（４−（（（２−（２，６−ジオキソピペリジン−３−イル）−１−オキソイソインドリン−４−イル）オキシ）メチル）ベンジル）ピペラジン−１−イル）−３−フルオロベンゾニトリルのバイオマーカーの使用" (Inspection day 2024-04-12) .
| - | No. | Title | Inspection days |
|---|---|---|---|
| 1 | 特開2022-031478 | 卵巣癌の治療方法 | 2024-04-17 |
| 2 | 特表2021-525362 | 多発性骨髄腫を治療すること及び４−（４−（４−（（（２−（２，６−ジオキソピペリジン−３−イル）−１−オキソイソインドリン−４−イル）オキシ）メチル）ベンジル）ピペラジン−１−イル）−３−フルオロベンゾニトリルのバイオマーカーの使用 | 2024-04-12 |
| 3 | 特表2021-524495 | 酸化的ストレスおよびミトコンドリアストレスから，細胞を保護する組成物 | 2024-04-12 |
| 4 | 特表2021-517556 | 核酸ライブラリー作製のための組成物及び方法 | 2024-04-09 |
| 5 | 特開2021-072834 | ポリマー単位を含むポリマーの解析 | 2024-03-28 |
| 6 | 特許7467479 | 多発性骨髄腫の治療における抗増殖化合物及び第２の活性薬剤とそれらの併用方法 | 2024-03-22 |
| 7 | 特表2021-516049 | 組換えＴ細胞受容体遺伝子を用いて細胞ベースの治療薬を製造するための技法 | 2024-03-19 |
| 8 | 特表2021-519075 | 乳の核酸分析に関する方法 | 2024-03-19 |
| 9 | 特表2022-518510 | 薬物耐性ＭＹＣＯＰＬＡＳＭＡ ＧＥＮＩＴＡＬＩＵＭの検出 | 2024-03-15 |
| 10 | 特許7334914 | ｃＤＮＡディスプレイを用いた新規イムノＰＣＲ法 | 2024-03-15 |
| 11 | 特表2021-529821 | イムノグロブリンを除去又は減少させるための遺伝子治療ベクターの形質導入を増加または増強するための組成物および方法 | 2024-03-13 |
| 12 | 特開2022-120133 | デジタルＰＣＲ検出器、デジタルＰＣＲ定量検出方法、異なる体積のデジタルＰＣＲの定量解析方法、デジタルＰＣＲ検出方法、核酸検出微小球、核酸検出微小球製造方法、核酸検出微小球試薬キット及びハイスループット核酸検出方法 | 2024-03-12 |
| 13 | 特開2021-107422 | ドライアイの治療用医薬組成物 | 2024-03-08 |
| 14 | 特表2019-503665 | 抗ＶＥＧＦで処置された加齢黄斑変性症に罹患している患者の臨床転帰に遺伝変異型を関連付ける方法 | 2024-02-14 |
| 15 | 特許7438966 | ナノアレイおよびマイクロアレイを製造する方法 | 2024-02-13 |
| 16 | 特開2022-102386 | 遺伝子解析用サンプルの製造方法 | 2024-02-08 |
| 17 | 特許7434161 | タンパク質同定のための方法およびシステム | 2024-02-05 |
| 18 | 特許7434215 | 無細胞メチル化ＤＮＡを捕捉する方法及びその使用 | 2024-02-05 |
| 19 | 特表2021-502085 | サイトカイン誘導性ＳＨ２含有タンパク質（ＣＩＳＨ）遺伝子の遺伝子改変 | 2024-01-24 |
| 20 | 特開2021-180669 | 遺伝子発現の調節及び脱制御されたタンパク質発現のスクリーニング | 2024-01-16 |
Top Patents/Patent Applications with the Highest Number of Inspectioned
Of the patent applications filed in the last 10 years (2014-05-01 to 2024-04-30), 459 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.2. The most inspection patent is 特表2021-524495 "酸化的ストレスおよびミトコンドリアストレスから，細胞を保護する組成物" (8 times) , and the next most inspection patent is 特許6426670 "真核生物細胞を改変する方法" (6 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特表2021-524495 | 酸化的ストレスおよびミトコンドリアストレスから，細胞を保護する組成物 | 8 times |
| 2 | 特許6426670 | 真核生物細胞を改変する方法 | 6 times |
| 3 | 特開2018-203628 | 化粧料組成物又は飲食品組成物 | 6 times |
| 4 | 特許6402368 | 真核生物細胞を改変する方法 | 6 times |
| 5 | 特開2016-155809 | 狭窄病変および血栓溶解療法のための剪断による制御放出 | 5 times |
Cited cases
Top Patents/Patent Applications with the Highest Number of Cited
Of the patent applications filed in the last 10 years (2014-05-01 to 2024-04-30), 2,038 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.3. The most cited patent is 特開2014-217381 "ｍｉＲＮＡおよびｍｉＲＮＡ阻害分子に関する方法および組成物" (68 times) , and the next most cited patent is 特許6099228 "食品製品の提供方法" (54 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特開2014-217381 | ｍｉＲＮＡおよびｍｉＲＮＡ阻害分子に関する方法および組成物 | 68 times |
| 2 | 特許6099228 | 食品製品の提供方法 | 54 times |
| 3 | 特許7185009 | 細胞トランスフェクションのエレクトロポレーション装置及び方法 | 39 times |
| 4 | 特許6196343 | 免疫グロブリンに特異的に結合するタンパク質および免疫グロブリン結合性アフィニティーリガンド | 36 times |
| 5 | 特許6429337 | ミドリイシ属サンゴのための種間及び種内マイクロサテライトマーカー | 33 times |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
Please note the following points for use.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
Citation of patent application status and ranking information
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Graphs are image data.
Please note that the various graphs are image data, but we cannot provide them in text data.Scope of coverage for each goal/target
- Based on the description of each goal and target of the SDGs, we have set the scope of technologies to be covered based on our and e-Patent's past experience, etc. (in some cases, the search is based on social issues themselves). Therefore, please note that there is a possibility that this "SDGs Global Company Ranking from Patent Perspective" may not cover 100%.
- A population search formula is clearly indicated for each goal/target (database: Patent Integration). You may use the population search formula as it is, or you may improve it by yourself.
- This search covers patents and utility models, including both published and registered patents (design and design patents are excluded). The unit of count is the number of applications, not the number of patent families.
About the name collation and name control of applicants and right holders
- Company rankings are based on the results calculated by "Patent Integration", with Japanese organizations in Japanese and other companies in English (some are in Japanese).
- Company names may be the names of the companies at the time of application, but the results calculated by Patent Integration are used as is. Company names are used as they were at the time of application.
- Because of the fluctuation in the names of companies (i.e., applicant/right holder names in the patent information), there are cases where the same company appears more than once in the top 10. The number of applications filed by the same company in the top 10 is the total number of applications filed by the company.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.